Nature's Sunshine cuts 2026 sales and EBITDA outlook; names Ruth Perkins CFO
Nature's Sunshine reported second-quarter 2026 net sales up 2% to $117.0 million and gross profit margin up to 73.7%, but GAAP diluted earnings per share fell to $0.19 from $0.28. The company lowered its full-year 2026 net sales and adjusted EBITDA outlook, citing a stronger U.S. dollar and softness in China, and named Ruth Perkins as executive vice president and chief financial officer effective September 1, 2026.
Key points
- Q2 2026 net sales rose 2% to $117.0 million; GAAP net income attributable to common shareholders was $3.5 million, or $0.19 per diluted share, versus $5.3 million, or $0.28, a year earlier.
- Full-year 2026 net sales outlook was cut to $490 million to $500 million from $500 million to $515 million.
- Full-year 2026 adjusted EBITDA outlook was cut to $48 million to $52 million from $50 million to $54 million.
- Ruth Perkins appointed EVP and CFO effective September 1, 2026, with a $575,000 base salary and a target bonus of 70% of base salary.
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.